Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles.

Sekerdag E, Lüle S, Bozdağ Pehlivan S, Öztürk N, Kara A, Kaffashi A, Vural I, Işıkay I, Yavuz B, Oguz KK, Söylemezoğlu F, Gürsoy-Özdemir Y, Mut M.

J Control Release. 2017 Sep 10;261:187-198. doi: 10.1016/j.jconrel.2017.06.032. Epub 2017 Jul 3.

PMID:
28684169
2.

Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma.

Kaffashi A, Lüle S, Bozdağ Pehlivan S, Sarısözen C, Vural İ, Koşucu H, Demir T, Buğdaycı KE, Söylemezoğlu F, Karlı Oğuz K, Mut M.

J Pharm Pharmacol. 2017 Aug;69(8):1010-1021. doi: 10.1111/jphp.12740. Epub 2017 May 4.

PMID:
28471040
3.

Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.

Alex AT, Joseph A, Shavi G, Rao JV, Udupa N.

Drug Deliv. 2016 Sep;23(7):2144-2153. Epub 2014 Dec 29.

PMID:
25544603
4.

Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.

Orunoğlu M, Kaffashi A, Pehlivan SB, Şahin S, Söylemezoğlu F, Oğuz KK, Mut M.

Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:32-38. doi: 10.1016/j.msec.2017.03.292. Epub 2017 Apr 6.

PMID:
28575990
5.

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.

Karim R, Palazzo C, Evrard B, Piel G.

J Control Release. 2016 Apr 10;227:23-37. doi: 10.1016/j.jconrel.2016.02.026. Epub 2016 Feb 16. Review.

PMID:
26892752
6.

MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.

Timbie KF, Afzal U, Date A, Zhang C, Song J, Wilson Miller G, Suk JS, Hanes J, Price RJ.

J Control Release. 2017 Oct 10;263:120-131. doi: 10.1016/j.jconrel.2017.03.017. Epub 2017 Mar 11.

PMID:
28288892
7.

Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.

Martins SM, Sarmento B, Nunes C, Lúcio M, Reis S, Ferreira DC.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):488-502. doi: 10.1016/j.ejpb.2013.08.011. Epub 2013 Aug 27.

PMID:
23994244
8.

Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.

Belhadj Z, Ying M, Cao X, Hu X, Zhan C, Wei X, Gao J, Wang X, Yan Z, Lu W.

J Control Release. 2017 Jun 10;255:132-141. doi: 10.1016/j.jconrel.2017.04.006. Epub 2017 Apr 6.

PMID:
28390902
9.

Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer.

Grover A, Hirani A, Pathak Y, Sutariya V.

AAPS PharmSciTech. 2014 Dec;15(6):1562-8. doi: 10.1208/s12249-014-0165-0. Epub 2014 Aug 19.

10.

Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.

Song S, Mao G, Du J, Zhu X.

Drug Deliv. 2016 May;23(4):1404-8. doi: 10.3109/10717544.2015.1064186. Epub 2015 Jul 23.

PMID:
26203687
11.

Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X.

Biomaterials. 2011 Jun;32(18):4293-305. doi: 10.1016/j.biomaterials.2011.02.044. Epub 2011 Mar 21.

PMID:
21427009
12.

Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route.

Jain DS, Bajaj AN, Athawale RB, Shikhande SS, Pandey A, Goel PN, Gude RP, Patil S, Raut P.

Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:411-21. doi: 10.1016/j.msec.2016.03.015. Epub 2016 Mar 6.

PMID:
27040235
13.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
14.

Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.

Geldenhuys W, Wehrung D, Groshev A, Hirani A, Sutariya V.

Pharm Dev Technol. 2015 Jun;20(4):497-506. doi: 10.3109/10837450.2014.892130. Epub 2014 Mar 6.

PMID:
24597667
15.

Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.

Bi C, Wang A, Chu Y, Liu S, Mu H, Liu W, Wu Z, Sun K, Li Y.

Int J Nanomedicine. 2016 Dec 7;11:6547-6559. eCollection 2016.

16.

Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.

Manaspon C, Nasongkla N, Chaimongkolnukul K, Nittayacharn P, Vejjasilpa K, Kengkoom K, Boongird A, Hongeng S.

Pharm Res. 2016 Dec;33(12):2891-2903. Epub 2016 Aug 5.

PMID:
27495180
17.

The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.

Xu Y, Shen M, Li Y, Sun Y, Teng Y, Wang Y, Duan Y.

Oncotarget. 2016 Apr 12;7(15):20890-901. doi: 10.18632/oncotarget.7896.

18.

Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.

Dhami NK, Pandey RS, Jain UK, Chandra R, Madan J.

J Microencapsul. 2014;31(7):685-93. doi: 10.3109/02652048.2014.913725. Epub 2014 Jun 25.

PMID:
24963955
19.

Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?

Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, Zhu X, Zhu J.

Drug Deliv. 2016 Nov;23(9):3408-3416. Epub 2016 Jun 8.

PMID:
27181462
20.

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.

Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.

Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005. Epub 2010 Oct 8.

PMID:
20934500

Supplemental Content

Support Center